SlideShare a Scribd company logo
1 of 4
Process Development Studies on Maximizing Recovery and Purity of GFP from Chromatography
Fractions
Kathryn Howard
BEC 436, Golden LEAF Biomanufacturing Training and Education Center, North Carolina State
University
September 28, 2016
Introduction
Chromatography exploits the target protein’s
inherent properties to purify the solution by
allowing the protein to bind to a stationary resin
while impurities pass through the column. In
biopharmaceutical applications, it is common to
employ different types of chromatography in
succession for optimal recovery and purity.
The purpose of the experiments within the scope
of this lab report was to determine an
appropriate chromatography process for
capturing and intermediately polishing GFP
from a Q Sepharose FF Eluate stream. An
effective chromatography process is necessary
in order to maximize the amount of target
protein recovered while sufficiently purifying
the target protein. Establishing optimal
chromatography parameters was accomplished
by evaluating purity and recovery results from
both gradient and step elution.
Materials and Methods
Using a 5 mL HiTrap™ Q Sepharose FF
column, a breakthrough run was executed to
determine the dynamic binding capacity (DBC)
of Q Sepharose FF for GFP in clarified lysate.
The column was first equilibrated with 50mM
Tris buffer pH 8.0 before loading the GFP in
clarified lysate to allow the column to become
fully saturated. The column was then washed
with the same buffer and eluted using 50 mM
Tris pH 8.0 and 1M NaCl, collecting fractions
throughout the process. A breakthrough curve of
GFP concentrations in the fractions collected
and the fractions’ corresponding volumes was
created, for which the breakthrough volume,
defined as the point where 10% of the column
was saturated with GFP. Using this value, the
DBC was calculated using Equation 1. The
maximum volume of clarified GFP lysate that
could be loaded to the Pall LRC column for
capture chromatography was then calculated
using Equation 2.
Equation 1. DBC = (Co∙Vbthru)/Vbed,1
Equation 2. Vload = (0.5∙DBC∙Vbed,2)/Cload
The Pall LRC column was then equilibrated
using 50mM Tris buffer pH 8.0, and the Vload
from Equation 2 was fed to the column in order
to perform anion exchange chromatography
(AEX). The column was washed with the same
buffer prior to elution. For the step elution, 10
column volumes (CV) of 1M NaCl were fed to
the column, while gradient elution utilized 10-
20% 1M NaCl over 4 CVs. Fractions of 12mL
were collected for concentration and
fluorescence analysis, and appropriate fractions
were then pooled together for best purification
and recovery results.
For intermediate purification, Hydrophobic
Interaction Chromatography (HIC) was
employed. The column was equilibrated with
2M ammonium sulfate + 50mM Tris prior to
loading the column with a 1:1 mixture of
fraction pool + ammonium sulfate. The column
was then washed with the same buffer, and GFP
was eluted with 50mM Tris in a similar manner
as the previous step and gradient elution.
Results and Discussion
The first analysis completed involved
determining whether clarified GFP lysate or
purified GFP possessed a better binding
capacity. As shown in Table 1, purified GFP had
a significantly higher binding capacity due to
having less contaminants competing for column
binding.
GFP Sample DBC (mg/mL)
Clarified GFP Lysate 25.265
Purified GFP 83.1
Table 1. Comparison of DBC values for purified
GFP and clarified GFP lysate.
Figure 1 depicts the comparison between
recovery and purity of GFP in gradient elution.
Fraction pools that contribute high GFP
recovery while also highly purifying the protein
are ideal. While other fraction pools were
considered, the pool of samples A3-A12
provided the best compromise of percent of GFP
recovered as compared to an acceptable percent
of GFP purified. In all cases, purity was
calculated by dividing the total amount of GFP
by the amount of total protein in each fraction or
fraction pool.
Figure 1. Plot of % GFP recovery vs. % GFP
purity in AEX for gradient elution.
The results from step elution were not as
expected, since the calculated total GFP (in mg)
of some fraction pools exceeded the total GFP in
the feed, inhibiting comparison of the two
elution methods. However, as compared to step
elution, it is expected that gradient elution would
have a higher purity at a similar recovery due to
gradient allowing for impurities to unbind from
the column and elute prior to the strong salt
concentration eluting the GFP. While some
more tightly-bound impurities will still be
present, this method of eluting impurities earlier
in the capture step causes a higher purity of GFP
in the later fractions obtained, thereby reducing
any further purification necessary.
HIC was used for intermediate purification of
GFP, as the buffer used exposes the hydrophobic
regions of GFP and results in a conformational
change of the protein. This allows for increased
GFP binding to the column as compared to
impurities, resulting in a more pure product.
Figure 3 demonstrates the results obtained from
HIC for both step and gradient elution. The
same fraction pooling process as earlier was
used in order to determine the fraction pool that
delivered the best compromise of GFP recovered
as compared to percent of GFP purified; the
optimal fraction pools for each elution method
have been marked. As shown, gradient elution
provides a better GFP recovery for similar
purification. However, HIC caused a sizeable
reduction in the amount of GFP recovered after
this intermediate purification and did not offer
the purity desired after only reaching
approximately 80% purity at its highest.
Figure 2. Plot of % GFP recovery vs. % GFP
purity in HIC for gradient and step elution.
Conclusions
Utilizing gradient elution for HIC allowed for
GFP fraction volumes to contain less impurities
as compared to fraction volumes from step
elution. While an effective comparison could not
be deduced from the data collected, it is
expected that the same analysis would be true
for the previous AEX step due to the timing of
impurity elution. However, both elution methods
would cause a decrease in percent of GFP purity
as percent GFP recovery increases since a larger
fraction pool will inherently allow for greater
possibility of impurities.
References
Introduction to Downstream Processing - BEC
436/536 Course Pack. North Carolina State
University: Golden LEAF Biomanufacturing
Training and Education Center, Fall 2016.
Print.
Lab Report #2

More Related Content

What's hot

FFW 2016 Poster_Cristallo
FFW 2016 Poster_CristalloFFW 2016 Poster_Cristallo
FFW 2016 Poster_Cristallo
Tara Cristallo
 
Cold On-Column Injection Amines by GC; Bonilla, Enriquez, McNair, 1997, J Chr...
Cold On-Column Injection Amines by GC; Bonilla, Enriquez, McNair, 1997, J Chr...Cold On-Column Injection Amines by GC; Bonilla, Enriquez, McNair, 1997, J Chr...
Cold On-Column Injection Amines by GC; Bonilla, Enriquez, McNair, 1997, J Chr...
Leopoldo G. Enriquez, Ph.D.
 
Smith_ProteinScience_2013
Smith_ProteinScience_2013Smith_ProteinScience_2013
Smith_ProteinScience_2013
Austin Smith
 
Abraham model correlations for ionic liquid solvents computational methodolog...
Abraham model correlations for ionic liquid solvents computational methodolog...Abraham model correlations for ionic liquid solvents computational methodolog...
Abraham model correlations for ionic liquid solvents computational methodolog...
Bihan Jiang
 
Quantative Structure-Activity Relationships (QSAR)
Quantative Structure-Activity Relationships (QSAR)Quantative Structure-Activity Relationships (QSAR)
Quantative Structure-Activity Relationships (QSAR)
Atai Rabby
 
BarreraBasnetDelgadoLamichhaneShifatuShrestha_Report2_4140_S13
BarreraBasnetDelgadoLamichhaneShifatuShrestha_Report2_4140_S13BarreraBasnetDelgadoLamichhaneShifatuShrestha_Report2_4140_S13
BarreraBasnetDelgadoLamichhaneShifatuShrestha_Report2_4140_S13
Juan Barrera
 

What's hot (20)

FFW 2016 Poster_Cristallo
FFW 2016 Poster_CristalloFFW 2016 Poster_Cristallo
FFW 2016 Poster_Cristallo
 
poster template 2015 4501
poster template 2015 4501poster template 2015 4501
poster template 2015 4501
 
Prep Symposium | Poster July, 2015
Prep Symposium | Poster July, 2015Prep Symposium | Poster July, 2015
Prep Symposium | Poster July, 2015
 
SIMONA CAVALU_Raman and Surface Enhanced Raman Spectroscopy of 2,2,5,5-Tetram...
SIMONA CAVALU_Raman and Surface Enhanced Raman Spectroscopy of 2,2,5,5-Tetram...SIMONA CAVALU_Raman and Surface Enhanced Raman Spectroscopy of 2,2,5,5-Tetram...
SIMONA CAVALU_Raman and Surface Enhanced Raman Spectroscopy of 2,2,5,5-Tetram...
 
Virendra
VirendraVirendra
Virendra
 
Pielak_JACS
Pielak_JACSPielak_JACS
Pielak_JACS
 
Analytical Method Development and Validation for Simultaneous Estimation of L...
Analytical Method Development and Validation for Simultaneous Estimation of L...Analytical Method Development and Validation for Simultaneous Estimation of L...
Analytical Method Development and Validation for Simultaneous Estimation of L...
 
Computational and Experimental Studies of MTO Catalyzed Olefin Hydrogenation
Computational and Experimental Studies of MTO Catalyzed Olefin HydrogenationComputational and Experimental Studies of MTO Catalyzed Olefin Hydrogenation
Computational and Experimental Studies of MTO Catalyzed Olefin Hydrogenation
 
Cold On-Column Injection Amines by GC; Bonilla, Enriquez, McNair, 1997, J Chr...
Cold On-Column Injection Amines by GC; Bonilla, Enriquez, McNair, 1997, J Chr...Cold On-Column Injection Amines by GC; Bonilla, Enriquez, McNair, 1997, J Chr...
Cold On-Column Injection Amines by GC; Bonilla, Enriquez, McNair, 1997, J Chr...
 
Smith_ProteinScience_2013
Smith_ProteinScience_2013Smith_ProteinScience_2013
Smith_ProteinScience_2013
 
FTIR Lab Report
FTIR Lab ReportFTIR Lab Report
FTIR Lab Report
 
ElogDoct: A Tool for Lipophilicity Determination in Drug Discovery. 2. Basic ...
ElogDoct: A Tool for Lipophilicity Determination in Drug Discovery. 2. Basic ...ElogDoct: A Tool for Lipophilicity Determination in Drug Discovery. 2. Basic ...
ElogDoct: A Tool for Lipophilicity Determination in Drug Discovery. 2. Basic ...
 
QSAR
QSARQSAR
QSAR
 
Chemical kinetics- Physical Chemistry
Chemical kinetics- Physical ChemistryChemical kinetics- Physical Chemistry
Chemical kinetics- Physical Chemistry
 
Abraham model correlations for ionic liquid solvents computational methodolog...
Abraham model correlations for ionic liquid solvents computational methodolog...Abraham model correlations for ionic liquid solvents computational methodolog...
Abraham model correlations for ionic liquid solvents computational methodolog...
 
Structural proteomics of glutathionylation and glycation of erythrocyte prote...
Structural proteomics of glutathionylation and glycation of erythrocyte prote...Structural proteomics of glutathionylation and glycation of erythrocyte prote...
Structural proteomics of glutathionylation and glycation of erythrocyte prote...
 
Quantative Structure-Activity Relationships (QSAR)
Quantative Structure-Activity Relationships (QSAR)Quantative Structure-Activity Relationships (QSAR)
Quantative Structure-Activity Relationships (QSAR)
 
BarreraBasnetDelgadoLamichhaneShifatuShrestha_Report2_4140_S13
BarreraBasnetDelgadoLamichhaneShifatuShrestha_Report2_4140_S13BarreraBasnetDelgadoLamichhaneShifatuShrestha_Report2_4140_S13
BarreraBasnetDelgadoLamichhaneShifatuShrestha_Report2_4140_S13
 
Thesis-abstract
Thesis-abstractThesis-abstract
Thesis-abstract
 
JB REU Report
JB REU ReportJB REU Report
JB REU Report
 

Similar to Lab Report #2

Hydrophobic interaction chromatography (1)
Hydrophobic interaction chromatography (1)Hydrophobic interaction chromatography (1)
Hydrophobic interaction chromatography (1)
Rakesh Kumar
 
laser-induced fluorescence orUV detectors for analysis of EPO and Tobramycin ...
laser-induced fluorescence orUV detectors for analysis of EPO and Tobramycin ...laser-induced fluorescence orUV detectors for analysis of EPO and Tobramycin ...
laser-induced fluorescence orUV detectors for analysis of EPO and Tobramycin ...
Wael Ebied
 
Nature BioTech RainDance.pdf
Nature BioTech RainDance.pdfNature BioTech RainDance.pdf
Nature BioTech RainDance.pdf
Michael Weiner
 
Bio390 final paper
Bio390 final paperBio390 final paper
Bio390 final paper
lcklemm
 
Advanced Biochemistry Lab
Advanced Biochemistry Lab Advanced Biochemistry Lab
Advanced Biochemistry Lab
Hannah Barber
 

Similar to Lab Report #2 (20)

Intensified polishing using single-pass tangential flow filtration (SPTFF) wi...
Intensified polishing using single-pass tangential flow filtration (SPTFF) wi...Intensified polishing using single-pass tangential flow filtration (SPTFF) wi...
Intensified polishing using single-pass tangential flow filtration (SPTFF) wi...
 
Quantification of a Novel Peptide, CPT31 in Rat and Monkey Plasma by LC-MS
Quantification of a Novel Peptide, CPT31 in Rat and Monkey Plasma by LC-MSQuantification of a Novel Peptide, CPT31 in Rat and Monkey Plasma by LC-MS
Quantification of a Novel Peptide, CPT31 in Rat and Monkey Plasma by LC-MS
 
HPLC Combinatorial Libraries
HPLC Combinatorial LibrariesHPLC Combinatorial Libraries
HPLC Combinatorial Libraries
 
VALIDATION AND DETERMINATION OF CAFFEINE CONTENT IN ENERGY DRINKS BY USING HP...
VALIDATION AND DETERMINATION OF CAFFEINE CONTENT IN ENERGY DRINKS BY USING HP...VALIDATION AND DETERMINATION OF CAFFEINE CONTENT IN ENERGY DRINKS BY USING HP...
VALIDATION AND DETERMINATION OF CAFFEINE CONTENT IN ENERGY DRINKS BY USING HP...
 
FINAL BIOCHEM PAPER
FINAL BIOCHEM PAPERFINAL BIOCHEM PAPER
FINAL BIOCHEM PAPER
 
Characterization of intact antibodies by pre-fractionation using gel electrop...
Characterization of intact antibodies by pre-fractionation using gel electrop...Characterization of intact antibodies by pre-fractionation using gel electrop...
Characterization of intact antibodies by pre-fractionation using gel electrop...
 
Online Size-Exclusion High-Performance Liquid Chromatography Light Scattering...
Online Size-Exclusion High-Performance Liquid Chromatography Light Scattering...Online Size-Exclusion High-Performance Liquid Chromatography Light Scattering...
Online Size-Exclusion High-Performance Liquid Chromatography Light Scattering...
 
Prabhakar singh ii sem-paper v-hplc, fplc, uplc, rrlc
Prabhakar singh  ii sem-paper v-hplc, fplc, uplc, rrlcPrabhakar singh  ii sem-paper v-hplc, fplc, uplc, rrlc
Prabhakar singh ii sem-paper v-hplc, fplc, uplc, rrlc
 
Hydrophobic interaction chromatography (1)
Hydrophobic interaction chromatography (1)Hydrophobic interaction chromatography (1)
Hydrophobic interaction chromatography (1)
 
Biomimetic hplc methods to predict in vivo drug distribution
Biomimetic hplc methods to predict in vivo drug distributionBiomimetic hplc methods to predict in vivo drug distribution
Biomimetic hplc methods to predict in vivo drug distribution
 
laser-induced fluorescence orUV detectors for analysis of EPO and Tobramycin ...
laser-induced fluorescence orUV detectors for analysis of EPO and Tobramycin ...laser-induced fluorescence orUV detectors for analysis of EPO and Tobramycin ...
laser-induced fluorescence orUV detectors for analysis of EPO and Tobramycin ...
 
RP_HPLC METHOD FOR   ESTIMATION  OF BUPROPION HCL IN BULKAND ITS  PHARMAC...
 RP_HPLC METHOD   FOR   ESTIMATION  OF BUPROPION HCL IN BULKAND  ITS  PHARMAC... RP_HPLC METHOD   FOR   ESTIMATION  OF BUPROPION HCL IN BULKAND  ITS  PHARMAC...
RP_HPLC METHOD FOR   ESTIMATION  OF BUPROPION HCL IN BULKAND ITS  PHARMAC...
 
Dorobantu Adina BMS2 - Molecular Biology FLR.pdf
Dorobantu Adina BMS2 - Molecular Biology FLR.pdfDorobantu Adina BMS2 - Molecular Biology FLR.pdf
Dorobantu Adina BMS2 - Molecular Biology FLR.pdf
 
Ex Bio 2016 poster
Ex Bio 2016 posterEx Bio 2016 poster
Ex Bio 2016 poster
 
Stability indicating RP-HPLC method for estimation of dapagliflozin in bulk a...
Stability indicating RP-HPLC method for estimation of dapagliflozin in bulk a...Stability indicating RP-HPLC method for estimation of dapagliflozin in bulk a...
Stability indicating RP-HPLC method for estimation of dapagliflozin in bulk a...
 
Analysis of bioreactor parameters online and offline
Analysis of bioreactor parameters online and offlineAnalysis of bioreactor parameters online and offline
Analysis of bioreactor parameters online and offline
 
Nature BioTech RainDance.pdf
Nature BioTech RainDance.pdfNature BioTech RainDance.pdf
Nature BioTech RainDance.pdf
 
PurificationAH
PurificationAHPurificationAH
PurificationAH
 
Bio390 final paper
Bio390 final paperBio390 final paper
Bio390 final paper
 
Advanced Biochemistry Lab
Advanced Biochemistry Lab Advanced Biochemistry Lab
Advanced Biochemistry Lab
 

Lab Report #2

  • 1. Process Development Studies on Maximizing Recovery and Purity of GFP from Chromatography Fractions Kathryn Howard BEC 436, Golden LEAF Biomanufacturing Training and Education Center, North Carolina State University September 28, 2016 Introduction Chromatography exploits the target protein’s inherent properties to purify the solution by allowing the protein to bind to a stationary resin while impurities pass through the column. In biopharmaceutical applications, it is common to employ different types of chromatography in succession for optimal recovery and purity. The purpose of the experiments within the scope of this lab report was to determine an appropriate chromatography process for capturing and intermediately polishing GFP from a Q Sepharose FF Eluate stream. An effective chromatography process is necessary in order to maximize the amount of target protein recovered while sufficiently purifying the target protein. Establishing optimal chromatography parameters was accomplished by evaluating purity and recovery results from both gradient and step elution. Materials and Methods Using a 5 mL HiTrap™ Q Sepharose FF column, a breakthrough run was executed to determine the dynamic binding capacity (DBC) of Q Sepharose FF for GFP in clarified lysate. The column was first equilibrated with 50mM Tris buffer pH 8.0 before loading the GFP in clarified lysate to allow the column to become fully saturated. The column was then washed with the same buffer and eluted using 50 mM Tris pH 8.0 and 1M NaCl, collecting fractions throughout the process. A breakthrough curve of GFP concentrations in the fractions collected and the fractions’ corresponding volumes was created, for which the breakthrough volume, defined as the point where 10% of the column was saturated with GFP. Using this value, the DBC was calculated using Equation 1. The maximum volume of clarified GFP lysate that could be loaded to the Pall LRC column for capture chromatography was then calculated using Equation 2. Equation 1. DBC = (Co∙Vbthru)/Vbed,1 Equation 2. Vload = (0.5∙DBC∙Vbed,2)/Cload The Pall LRC column was then equilibrated using 50mM Tris buffer pH 8.0, and the Vload from Equation 2 was fed to the column in order to perform anion exchange chromatography (AEX). The column was washed with the same buffer prior to elution. For the step elution, 10 column volumes (CV) of 1M NaCl were fed to the column, while gradient elution utilized 10- 20% 1M NaCl over 4 CVs. Fractions of 12mL were collected for concentration and fluorescence analysis, and appropriate fractions were then pooled together for best purification and recovery results. For intermediate purification, Hydrophobic Interaction Chromatography (HIC) was employed. The column was equilibrated with 2M ammonium sulfate + 50mM Tris prior to loading the column with a 1:1 mixture of fraction pool + ammonium sulfate. The column was then washed with the same buffer, and GFP was eluted with 50mM Tris in a similar manner as the previous step and gradient elution. Results and Discussion The first analysis completed involved determining whether clarified GFP lysate or purified GFP possessed a better binding capacity. As shown in Table 1, purified GFP had a significantly higher binding capacity due to
  • 2. having less contaminants competing for column binding. GFP Sample DBC (mg/mL) Clarified GFP Lysate 25.265 Purified GFP 83.1 Table 1. Comparison of DBC values for purified GFP and clarified GFP lysate. Figure 1 depicts the comparison between recovery and purity of GFP in gradient elution. Fraction pools that contribute high GFP recovery while also highly purifying the protein are ideal. While other fraction pools were considered, the pool of samples A3-A12 provided the best compromise of percent of GFP recovered as compared to an acceptable percent of GFP purified. In all cases, purity was calculated by dividing the total amount of GFP by the amount of total protein in each fraction or fraction pool. Figure 1. Plot of % GFP recovery vs. % GFP purity in AEX for gradient elution. The results from step elution were not as expected, since the calculated total GFP (in mg) of some fraction pools exceeded the total GFP in the feed, inhibiting comparison of the two elution methods. However, as compared to step elution, it is expected that gradient elution would have a higher purity at a similar recovery due to gradient allowing for impurities to unbind from the column and elute prior to the strong salt concentration eluting the GFP. While some more tightly-bound impurities will still be present, this method of eluting impurities earlier in the capture step causes a higher purity of GFP in the later fractions obtained, thereby reducing any further purification necessary. HIC was used for intermediate purification of GFP, as the buffer used exposes the hydrophobic regions of GFP and results in a conformational change of the protein. This allows for increased GFP binding to the column as compared to impurities, resulting in a more pure product. Figure 3 demonstrates the results obtained from HIC for both step and gradient elution. The same fraction pooling process as earlier was used in order to determine the fraction pool that delivered the best compromise of GFP recovered as compared to percent of GFP purified; the optimal fraction pools for each elution method have been marked. As shown, gradient elution provides a better GFP recovery for similar purification. However, HIC caused a sizeable reduction in the amount of GFP recovered after this intermediate purification and did not offer the purity desired after only reaching approximately 80% purity at its highest. Figure 2. Plot of % GFP recovery vs. % GFP purity in HIC for gradient and step elution. Conclusions Utilizing gradient elution for HIC allowed for GFP fraction volumes to contain less impurities as compared to fraction volumes from step elution. While an effective comparison could not be deduced from the data collected, it is expected that the same analysis would be true for the previous AEX step due to the timing of impurity elution. However, both elution methods would cause a decrease in percent of GFP purity as percent GFP recovery increases since a larger fraction pool will inherently allow for greater possibility of impurities. References
  • 3. Introduction to Downstream Processing - BEC 436/536 Course Pack. North Carolina State University: Golden LEAF Biomanufacturing Training and Education Center, Fall 2016. Print.